SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-177388
Filing Date
2015-05-07
Accepted
2015-05-07 17:17:42
Documents
18
Period of Report
2015-01-31

Document Format Files

Seq Description Document Type Size
1 20-F d917125d20f.htm 20-F 1635588
2 EX-8.1 d917125dex81.htm EX-8.1 2728
3 EX-12.1 d917125dex121.htm EX-12.1 5388
4 EX-12.2 d917125dex122.htm EX-12.2 5394
5 EX-13.1 d917125dex131.htm EX-13.1 3684
6 GRAPHIC g917125g02c30.jpg GRAPHIC 54175
7 GRAPHIC g917125g04o46.jpg GRAPHIC 26249
8 GRAPHIC g917125g18o29.jpg GRAPHIC 67638
9 GRAPHIC g917125g22f26.jpg GRAPHIC 43077
10 GRAPHIC g917125g24x15.jpg GRAPHIC 82327
11 GRAPHIC g917125g34p18.jpg GRAPHIC 40289
12 GRAPHIC g917125g46r63.jpg GRAPHIC 23752
13 GRAPHIC g917125g54r88.jpg GRAPHIC 55232
14 GRAPHIC g917125g63v98.jpg GRAPHIC 50336
15 GRAPHIC g917125g66a95.jpg GRAPHIC 80993
16 GRAPHIC g917125g68x57.jpg GRAPHIC 88774
17 GRAPHIC g917125g78k23.jpg GRAPHIC 25772
18 GRAPHIC g917125g86f07.jpg GRAPHIC 39772
  Complete submission text file 0001193125-15-177388.txt   2590516
Mailing Address 85B PARK DRIVE MILTON PARK ABINGDON X0 OX14 4RY
Business Address 85B PARK DRIVE MILTON PARK ABINGDON X0 OX14 4RY 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: 20-F | Act: 34 | File No.: 001-36866 | Film No.: 15843012
SIC: 2834 Pharmaceutical Preparations